IGFBP1
Basic information
Region (hg38): 7:45888360-45893660
Previous symbols: [ "IBP1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IGFBP1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 16 | 17 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 16 | 1 | 0 |
Variants in IGFBP1
This is a list of pathogenic ClinVar variants found in the IGFBP1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-45888732-C-T | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | ||
7-45888770-C-T | not specified | Uncertain significance (May 25, 2022) | ||
7-45888829-T-G | not specified | Uncertain significance (Dec 12, 2023) | ||
7-45888855-G-A | not specified | Uncertain significance (Nov 18, 2022) | ||
7-45888884-T-G | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | ||
7-45888894-G-T | not specified | Uncertain significance (Feb 10, 2022) | ||
7-45888969-A-C | not specified | Likely benign (Aug 17, 2021) | ||
7-45888975-C-T | not specified | Uncertain significance (Feb 27, 2024) | ||
7-45888981-C-A | not specified | Uncertain significance (Dec 27, 2023) | ||
7-45890551-C-A | not specified | Uncertain significance (Dec 21, 2023) | ||
7-45890586-A-C | not specified | Uncertain significance (Aug 02, 2021) | ||
7-45890671-A-G | not specified | Uncertain significance (Oct 27, 2023) | ||
7-45890680-C-T | not specified | Uncertain significance (Dec 20, 2022) | ||
7-45891962-G-A | not specified | Uncertain significance (Oct 28, 2023) | ||
7-45892000-A-T | not specified | Likely benign (Jun 02, 2024) | ||
7-45892973-T-C | not specified | Uncertain significance (Feb 15, 2023) | ||
7-45893035-T-A | not specified | Uncertain significance (Jan 30, 2024) | ||
7-45893038-C-G | not specified | Uncertain significance (Aug 02, 2021) | ||
7-45893046-C-G | not specified | Uncertain significance (Oct 20, 2023) | ||
7-45893051-G-T | not specified | Uncertain significance (Feb 28, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
IGFBP1 | protein_coding | protein_coding | ENST00000275525 | 4 | 5312 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000947 | 0.821 | 125718 | 0 | 11 | 125729 | 0.0000437 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.253 | 125 | 133 | 0.938 | 0.00000643 | 1634 |
Missense in Polyphen | 38 | 44.34 | 0.85701 | 586 | ||
Synonymous | -0.216 | 60 | 57.9 | 1.04 | 0.00000304 | 524 |
Loss of Function | 1.15 | 6 | 9.92 | 0.605 | 5.02e-7 | 114 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000620 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000585 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000177 | 0.0000176 |
Middle Eastern | 0.0000585 | 0.0000544 |
South Asian | 0.000247 | 0.000229 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors. Promotes cell migration. {ECO:0000269|PubMed:15972819}.;
- Pathway
- IGF-Ncore;ATF4 activates genes;Aryl Hydrocarbon Receptor Pathway;Vitamin D Receptor Pathway;Nuclear Receptors Meta-Pathway;Myometrial Relaxation and Contraction Pathways;Senescence-Associated Secretory Phenotype (SASP);Photodynamic therapy-induced HIF-1 survival signaling;Post-translational protein phosphorylation;Post-translational protein modification;Metabolism of proteins;IGF signaling;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);HIF-1-alpha transcription factor network;FOXA2 and FOXA3 transcription factor networks
(Consensus)
Recessive Scores
- pRec
- 0.747
Haploinsufficiency Scores
- pHI
- 0.600
- hipred
- N
- hipred_score
- 0.258
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.997
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Igfbp1
- Phenotype
- immune system phenotype; liver/biliary system phenotype; cellular phenotype;
Gene ontology
- Biological process
- signal transduction;aging;insulin receptor signaling pathway;positive regulation of cell growth;PERK-mediated unfolded protein response;tissue regeneration;regulation of insulin-like growth factor receptor signaling pathway;post-translational protein modification;cellular protein metabolic process;negative regulation of canonical Wnt signaling pathway
- Cellular component
- extracellular region;extracellular space;endoplasmic reticulum lumen;Golgi apparatus
- Molecular function
- signaling receptor binding;protein binding;insulin-like growth factor binding;insulin-like growth factor I binding;insulin-like growth factor II binding